My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 399

    1.

    The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?

    Baker SG, Kramer BS, Corle D.

    BMC Med Res Methodol. 2004 Oct 4;4:24.PMID: 15461821 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Interpretation of cancer prevention trials.

    Moon TE.

    Prev Med. 1989 Sep;18(5):721-31.PMID: 2694166 [PubMed - indexed for MEDLINE]Related articles

    3.

    Personalised risk communication for informed decision making about taking screening tests.

    Edwards AG, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001865. Review.PMID: 17054144 [PubMed - indexed for MEDLINE]Related articles

    4.

    Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

    Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

    Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.PMID: 16545208 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The net effect of alternative allocation ratios on recruitment time and trial cost.

    Vozdolska R, Sano M, Aisen P, Edland SD.

    Clin Trials. 2009 Apr;6(2):126-32.PMID: 19342464 [PubMed - indexed for MEDLINE]Related articles

    6.

    Some power considerations when deciding to use transformations.

    Kingman A, Zion G.

    Stat Med. 1994 Mar 15-Apr 15;13(5-7):769-83.PMID: 8023049 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dynamic wait-listed designs for randomized trials: new designs for prevention of youth suicide.

    Brown CH, Wyman PA, Guo J, Peña J.

    Clin Trials. 2006;3(3):259-71.PMID: 16895043 [PubMed - indexed for MEDLINE]Related articles

    8.

    The causes and effects of socio-demographic exclusions from clinical trials.

    Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

    Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.PMID: 16181564 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?

    Roozenbeek B, Maas AI, Lingsma HF, Butcher I, Lu J, Marmarou A, McHugh GS, Weir J, Murray GD, Steyerberg EW; IMPACT Study Group.

    Crit Care Med. 2009 Oct;37(10):2683-90.PMID: 19885979 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups.

    Nordentoft M.

    Dan Med Bull. 2007 Nov;54(4):306-69. Review.PMID: 18208680 [PubMed - indexed for MEDLINE]Related articles

    11.

    Statistical aspects of controlled single subject trials.

    Johannessen T, Fosstvedt D, Petersen H.

    Fam Pract. 1990 Dec;7(4):325-8.PMID: 2289647 [PubMed - indexed for MEDLINE]Related articles

    12.

    A group sequential, response-adaptive design for randomized clinical trials.

    Karrison TG, Huo D, Chappell R.

    Control Clin Trials. 2003 Oct;24(5):506-22. Review.PMID: 14500050 [PubMed - indexed for MEDLINE]Related articles

    13.

    The cost-effectiveness of testing for hepatitis C in former injecting drug users.

    Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

    Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.PMID: 16948891 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Randomized trials, generalizability, and meta-analysis: graphical insights for binary outcomes.

    Baker SG, Kramer BS.

    BMC Med Res Methodol. 2003 Jun 16;3:10. Epub 2003 Jun 16.PMID: 12809566 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

    van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, Prokop M, Habbema JD, Oudkerk M, van Klaveren RJ.

    Int J Cancer. 2007 Feb 15;120(4):868-74.PMID: 17131307 [PubMed - indexed for MEDLINE]Related articles

    16.

    Seven ways to increase power without increasing N.

    Hansen WB, Collins LM.

    NIDA Res Monogr. 1994;142:184-95. Review.PMID: 9243537 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

    Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

    Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.PMID: 18547499 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A strategic view of randomized trial design in low-incidence paediatric cancer.

    Sposto R, Stram DO.

    Stat Med. 1999 May 30;18(10):1183-97.PMID: 10363339 [PubMed - indexed for MEDLINE]Related articles

    19.

    A systematic review and economic evaluation of statins for the prevention of coronary events.

    Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

    Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Mixed noninferiority margin and statistical tests in active controlled trials.

    Tsou HH, Hsiao CF, Chow SC, Yue L, Xu Y, Lee S.

    J Biopharm Stat. 2007;17(2):339-57.PMID: 17365228 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity